If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Pediatric Allergy and ImmunologyVolume 18 Issue 6, Pages 475 - 479 Published Online: 11 Jun 2007 © 2010 John Wiley & Sons A/S Official Journal of the European Academy of Allergy and Clinical Immunology (EAACI)
Abstract | References | Full Text: HTML, PDF (Size: 468K) | Related Articles | Citation Tracking Dietary prevention of allergic disease in children: Are current recommendations really based on good evidence? Copyright 2007 The Authors Journal compilation 2007 Blackwell Munksgaard KEYWORDS hypoallergenic infant formula • protein hydrolysates • allergy prevention • cow's milk allergy • atopic eczema Brand PLP, Vlieg-Boerstra BJ, Dubois AEJ. Dietary prevention of allergic disease in children: Are current recommendations really based on good evidence? Pediatr Allergy Immunol 2007. 18: 475–479. © 2007 The Authors Journal compilation © 2007 Blackwell Munksgaard ABSTRACTWe provide a critical appraisal of the literature on the effects of dietary prevention of atopic disease in children. In our view, currently available studies suffer from lack of blinding which is a major problem if the primary end point is subjective (such as the diagnosis of eczema). In addition, long-term follow-up suggests that atopic symptoms are delayed rather than truly prevented, and that only the mildest cases are prevented (or delayed). Although it has been reported that cow's milk allergy is truly prevented by dietary interventions in early life, this has never been demonstrated by double-blind placebo-controlled food challenges. No studies to date have shown effects of hypoallergenic formulae on objective markers of atopic sensitization, such as specific IgE levels. Finally, there is no universally accepted pathophysiological mechanism which could explain the usefulness of hypoallergenic formulae in allergy prevention. In conclusion, we feel that the currently available evidence on the allergy preventive effects of hypoallergenic formulae is insufficient to justify blanket advice being given to 'high risk' families. Such advice gives parents the hope that they can actually prevent allergy in their children which may not be justified. A cautious approach in advising interventions with hypoallergenic formulae to prevent allergy in high-risk infants is warranted. Accepted 13 January 2007 |